BioGaia AB (publ)
BIOGY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.26B
Close$
$10.06
19.2% downside
Current Fair Value
19.2% downsideOvervalued by 19.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.26 Billion |
|---|---|
| Enterprise Value | $812.72 Million |
| Annual dividend | $0.42 |
| Dividend yield | 3.32% |
| Earnings per Share | $3.29 |
| Beta | 0.32 |
| Outstanding Shares | 101,124,000 |
Return
| Return on Equity | 35.41% |
|---|---|
| Return on Assets | 29.18% |
| Return on Invested Capital | 53.25% |
Valuation & Multiples
| P/E Ratio | 31.11 |
|---|---|
| PEG | 46.26 |
| Price to Sales | 0.78 |
| Price to Book Ratio | 1.25 |
| Enterprise Value to Revenue | 0.49 |
| Enterprise Value to EBIT | 1.36 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 22, 2026
EPS Estimate
$0.90
Consensus analyst estimateRevenue Estimate
$383.54 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BioGaia AB (publ)
251 employees
CEO: Theresa Agnew
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantag...